Evidence map›Paper›PMID 39834035›Full record

ReviewThe Clinical neuropsychologist2025

Chronic traumatic encephalopathy: State-of-the-science update and narrative review.

Breton M Asken, Benjamin L Brett, William B Barr, Sarah Banks, Jennifer V Wethe, Kristen Dams-O'Connor, Robert A Stern, Michael L Alosco

Abstract readReview
In one paragraph

Review in The Clinical neuropsychologist, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Breton M AskenDepartment of Clinical and Health Psychology, University of Florida, 1Florida Alzheimer's Disease Research Center, Gainesville, FL, USA.ORCID 0000-0001-8419-142X
Benjamin L BrettDepartment of Neurosurgery, Medical College of Wisconsin, Milwaukee, WS, USA.ORCID 0000-0003-2849-4658
William B BarrDepartment of Neurology, New York University Langone Health Medical Center, New York, NY, USA.
Sarah BanksDepartment of Neuroscience, University of California San Diego, La Jolla, CA, USA.
Jennifer V WetheDepartments of Psychiatry and Psychology, Mayo Clinic, Phoenix, AZ, USA.
Kristen Dams-O'ConnorDepartments of Rehabilitation Medicine and Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.ORCID 0000-0002-2506-0216
Robert A SternDepartments of Neurology, Neurosurgery, and Anatomy & Neurobiology, Boston University Chobanian & Avedisian School of Medicine, Boston University CTE and Alzheimer's Disease Research Centers, Boston, MA, USA.
Michael L AloscoDepartments of Neurology and Anatomy & Neurobiology, Boston University Chobanian & Avedisian School of Medicine, Boston University CTE and Alzheimer's Disease Research Centers, Boston, MA, USA.

Funding

The Late Effects of TBI (LETBI) Study: Injury Patterns and Biological Markers of Post-Traumatic NeurodegenerationRF1NS115268 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Kristen Dams-O'Connor · 2019 to 2026
$10.3M
Leveraging Existing Aging Research Networks to investigate TBI and AD/ADRD risk (LEARN TBI & AD)R01AG061028 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DAMS-O'CONNOR, KRISTEN, MEZ, JESSE BENJAMIN · 2019 to 2023
$5.9M
Clinical & biological signatures of post-traumatic neurodegeneration: Leveraging the TBI Model Systems of Care to accelerate in vivo diagnosis of the late effects of TBI (LETBI)RF1NS128961 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DAMS-O'CONNOR, KRISTEN · 2022 to 2022
$5.0M
Clinical & biological signatures of post-traumatic neurodegeneration: Leveraging the TBI Model Systems of Care to accelerate in vivo diagnosis of the late effects of TBI (LETBI)R01NS128961 · NINDS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Kristen Dams-O'Connor · 2025 to 2026
$3.3M
Late Pathologies of Exposure to Repetitive Head Impacts from Contact Sports: White Matter and Vascular Contributions to Cognitive Impairment, Dementia, and Neuropsychiatric SymptomsRF1NS122854 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ALOSCO, MICHAEL, MCKEE, ANN C. · 2021 to 2021
$2.3M
Blood Biomarker Development and Validation in Chronic Traumatic Encephalopathy and Alzheimer's Disease and Alzheimer's Disease Related DementiasRF1NS132290 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ALOSCO, MICHAEL, STEIN, THOR · 2023 to 2023
$1.9M
Late Pathologies of Exposure to Repetitive Head Impacts from Contact Sports: White Matter and Vascular Contributions to Cognitive Impairment, Dementia, and Neuropsychiatric SymptomsR01NS122854 · NINDS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ALOSCO, MICHAEL, MCKEE, ANN C. · 2024 to 2025
$1.6M
The effects of cumulative concussion, repetitive head impacts, and comorbid cardiovascular risk factors on MRI metrics of pathological aging and neurobehavioral functioning across the lifespanK23AG073528 · NIA · MEDICAL COLLEGE OF WISCONSIN · PI BRETT, BENJAMIN L · 2021 to 2025
$661k
NIA NIH HHS K23 AG073528NIA NIH HHS R01 AG061028NINDS NIH HHS L30 NS113158NINDS NIH HHS R01 NS122854NINDS NIH HHS R01 NS128961NINDS NIH HHS RF1 NS115268NINDS NIH HHS RF1 NS122854NINDS NIH HHS RF1 NS128961NINDS NIH HHS RF1 NS132290
6 · The paper itself

Abstract

objectiveThe long-recognized association of brain injury with increased risk of dementia has undergone significant refinement and more detailed study in recent decades. Chronic traumatic encephalopathy (CTE) is a specific neurodegenerative tauopathy related to prior exposure to repetitive head impacts (RHI). We aim to contextualize CTE within a historical perspective and among emerging data which highlights the scientific and conceptual evolution of CTE-related research in parallel with the broader field of neurodegenerative disease and dementia.

methodsWe provide a narrative state-of-the-science update on CTE neuropathology, clinical manifestations, biomarkers, different types and patterns of head impact exposure relevant for CTE, and the complicated influence of neurodegenerative co-pathology on symptoms.

conclusionsNow almost 20 years since the initial case report of CTE in a former American football player, the field of CTE continues evolving with increasing clarity but also several ongoing controversies. Our understanding of CTE neuropathology outpaces that of disease-specific clinical correlates or the development of in-vivo biomarkers. Diagnostic criteria for symptoms attributable to CTE are still being validated, but leveraging increasingly available biomarkers for other conditions like Alzheimer's disease may be helpful for informing the CTE differential diagnosis. As diagnostic refinement efforts advance, clinicians should provide care and/or referrals to providers best suited to treat an individual patient's clinical symptoms, many of which have evidence-based behavioral treatment options that are etiologically agnostic. Several ongoing research initiatives and the gradual accrual of gold standard clinico-pathological data will pay dividends for advancing the many existing gaps in the field of CTE.

Indexed as

Chronic Traumatic EncephalopathyBiomarkersHumansBiomarkersAlzheimer’s disease and related dementiasChronic traumatic encephalopathyrepetitive head impactstraumatic brain injurytraumatic encephalopathy syndrome

Identifiers

PMID39834035
PMCPMC12276948

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.